A Pilot Study to Evaluate the Lipid Effects of TRIA-662

NCT02008084 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia
Mixed Hyperlipidemia

Interventions

DRUG: TRIA-662
DRUG: Placebo

Sponsor

Cortria Corporation

Collaborators

[object Object]